TY - JOUR
T1 - The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders
AU - Heim, Christine
AU - Nemeroff, Charles B.
N1 - Funding Information:
The authors are supported by NIH MH-42088, NIH MH-50113, and DFG He2561/2-1.
Funding Information:
This work was presented at the scientific satellite conference, “The Role of Biological and Psychological Factors on Early Development and Their Impact on Adult Life,” that preceded the Anxiety Disorders Association of America (ADAA) annual meeting, San Diego, March 1999. The conference was jointly sponsored by the ADAA and the National Institute of Mental Health through an unrestricted educational grant provided by Wyeth-Ayerst Laboratories.
PY - 1999/12/1
Y1 - 1999/12/1
N2 - The relative contribution of genetic and environmental factors to the development of the major psychiatric disorders has long been debated. Recently, considerable attention has been given to the observations that adverse experiences early in life predispose individuals to the development of affective and anxiety disorders in adulthood. Corticotropin-releasing factor (CRF) is the central coordinator of the endocrinologic, autonomic, immunologic, and behavioral stress responses. When centrally administered, CRF produces many physiologic and behavioral changes reminiscent of both acute stress and depression. Moreover, CRF has also been implicated in the pathogenesis of a variety of anxiety disorders, mainly through CRF neurocircuits connecting the amygdala and the locus ceruleus. Clinical studies have provided convincing evidence for central CRF hypersecretion in depression, and, to a lesser extent, in some anxiety disorders. Evidence mainly from preclinical studies suggests that stress early in life results in persistent central CRF hyperactivity and increased stress reactivity in adulthood. Thus, genetic disposition coupled with early stress in critical phases of development may result in a phenotype that is neurobiologically vulnerable to stress and may lower an individual's threshold for developing depression and anxiety upon further stress exposure. This pathophysiologic model may provide novel approaches to the prevention and treatment of psychopathology associated with stress early in life. Copyright (C) 1999 Society of Biological Psychiatry.
AB - The relative contribution of genetic and environmental factors to the development of the major psychiatric disorders has long been debated. Recently, considerable attention has been given to the observations that adverse experiences early in life predispose individuals to the development of affective and anxiety disorders in adulthood. Corticotropin-releasing factor (CRF) is the central coordinator of the endocrinologic, autonomic, immunologic, and behavioral stress responses. When centrally administered, CRF produces many physiologic and behavioral changes reminiscent of both acute stress and depression. Moreover, CRF has also been implicated in the pathogenesis of a variety of anxiety disorders, mainly through CRF neurocircuits connecting the amygdala and the locus ceruleus. Clinical studies have provided convincing evidence for central CRF hypersecretion in depression, and, to a lesser extent, in some anxiety disorders. Evidence mainly from preclinical studies suggests that stress early in life results in persistent central CRF hyperactivity and increased stress reactivity in adulthood. Thus, genetic disposition coupled with early stress in critical phases of development may result in a phenotype that is neurobiologically vulnerable to stress and may lower an individual's threshold for developing depression and anxiety upon further stress exposure. This pathophysiologic model may provide novel approaches to the prevention and treatment of psychopathology associated with stress early in life. Copyright (C) 1999 Society of Biological Psychiatry.
UR - http://www.scopus.com/inward/record.url?scp=0032730256&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032730256&partnerID=8YFLogxK
U2 - 10.1016/S0006-3223(99)00224-3
DO - 10.1016/S0006-3223(99)00224-3
M3 - Article
C2 - 10599479
AN - SCOPUS:0032730256
SN - 0006-3223
VL - 46
SP - 1509
EP - 1522
JO - Biological Psychiatry
JF - Biological Psychiatry
IS - 11
ER -